+reprogramming
436 Results
Erweiterte Suche
Suchergebnisse
Suche eingrenzen Grenzen Sie Ihre Suche mit den nachstehenden Filtern ein
Pages by Application
By Industry
-
-
Press Release: Merck Honored by R&D Magazine for Innovation
Merck today announced it has received two prestigious R&D Magazine 100 awards - one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn't address. -
Stem Cell Research | Life Science Research | Merck
We offer a wide selection of stem cell research products including: human and murine stem cells, media optimized for stem cell and primary cell culture, growth factors, exclusive antibodies, cultureware, and kits to help you jump start your research. -
Proprietary Technologies | Support | Merck
We have proprietary technologies available for licensing. Learn more about our available technology and find contact information to get started. -
STEMCCA Lentivirus Reprogramming Kits | Life Science Research | Merck
STEMCCA kits use a single polycistronic lentiviral vector to improve efficiency and reduce the number of viral integrations. Work perfectly with iPS cells. -
Press Release: Merck Wins R&D 100 Award for Top Invention
Merck received a prestigious R&D 100 Award for its Sanger Arrayed Lentiviral CRISPR Libraries-the first of its kind CRISPR libraries. -
Boost Kits | Life Science Research | Merck
We have developed various reprogramming boost kits which contain small molecule inducers and inhibitors to increase the overall reprogram efficiencies achieved with any reprogramming method used. -
Stem Cell FAQs | Stem Cell Biomanufacturing | Merck
Here you will find fequently asked questions relating to understanding Stem Cells and stem cell therapy. -
Press Release: Merck Obtains Global Licensing Agreement for induced Pluripotent Stem(iPS) Cell Patent Technology with iPS Academia Japan, Inc. (AJ)
Merck and iPS Academia Japan, Inc. (Kyoto, Japan) today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio. -
iPS Cell Characterization | Life Science Research | Merck
Discover our classical ES/iPS cell characterization tools such as alkaline phosphate quantification and novel ES/iPS antibodies along with proprietary live cell staining kits to identify truly reprogrammed colonies without the need to discard cultures through cell fixation.